Abeona Therapeutics ABEO Cash Flow Statement (2010-2026)

NASDAQ ABEO
$6.01 +0.08 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Abeona Therapeutics Quarterly Cash Flow Statement

Periods 63 quarters
Latest Jun 2026

Abeona Therapeutics reported cash from operations of -$17.50M and free cash flow of -$17.98M for the quarter ended Jun 2026, up 6.9% year over year. This cash flow statement covers 63 quarters of results from Dec 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-15.55M-46.70M-20.79M-8.18M-9.54M-13.11M-12.14M-10.66M-11.44M-13.32M-15.28M7.41M-30.27M4.09M-12.03M124.34M-35.56M-35.33M-17.07M-20.19M
Share-based Compensation
2.54M2.00M0.86M0.72M0.63M0.83M0.77M0.93M1.56M1.51M1.55M1.32M1.80M1.96M2.70M2.83M2.69M-1.80M20.50M0.17M
Gains from Investment Securities
1.25M-4.20M-3.05M-5.39M-2.27M8.63M1.10M4.23M17.30M-24.93M15.16M-6.78M-7.25M5.39M-2.76M-1.52M-5.39M7.19M
Asset Writedowns and Impairment
3.30M-1.50M0.71M
Cash from Operations
-10.33M-30.26M-13.69M-9.01M-6.79M-13.99M-11.74M-10.28M-5.75M-9.23M-14.54M-12.68M-12.23M-16.56M-18.40M-18.78M-21.19M-17.95M-19.80M-17.50M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.28M0.39M0.30M0.60M0.30M0.28M0.23M0.22M0.23M0.23M0.23M0.20M0.23M0.24M-0.46M0.96M0.28M0.23M0.18M0.17M
Depreciation & Amortization (CF)Depreciation & Amortization
0.80M0.81M0.81M0.77M0.78M0.73M0.66M0.61M0.52M0.49M0.49M0.49M0.49M0.54M0.53M0.54M0.61M0.86M0.69M0.67M
Change in Working Capital
Change in Receivables
-3.00M1.00M-1.00M0.05M3.19M
Change in Inventory
2.16M0.64M0.56M-0.13M
Change in Account Payables
0.67M-20.00M-0.30M7.00M
Change in Accured Expenses
0.52M5.28M-4.39M0.70M-1.44M1.02M-0.38M2.21M-1.07M1.28M-1.69M1.57M-0.08M1.71M-2.38M3.68M1.00M4.24M-7.32M0.98M
Change in Taxes
0.11M15.34M-15.11M-0.21M-0.13M
Other Working Capital Changes
-0.41M1.47M-0.38M-0.56M-0.49M-0.52M1.20M-0.42M-1.68M-0.29M1.23M-0.59M-1.58M-0.37M0.87M0.08M0.12M-1.64M0.66M0.02M
Investing Activities
Capital Expenditures
0.40M3.25M-0.15M0.28M0.22M0.03M0.04M0.04M0.72M0.71M0.40M0.61M1.40M2.90M2.52M1.15M0.94M0.48M
Sales of Property, Plant and Equipment
0.10M0.14M0.01M0.02M
Change in Acquisitions & Divestments
27.16M16.25M8.66M24.07M10.97M8.94M10.39M11.26M15.36M14.97M22.25M17.11M50.87M29.96M54.26M98.11M14.90M24.90M40.87M
Cash from Investing Activities
26.76M8.00M1.07M-1.40M1.65M-25.29M2.21M5.21M-18.74M11.53M-7.82M-44.13M-6.17M18.88M4.21M155.89M-64.63M9.55M4.96M15.69M
Financing Activities
Other financing activities
0.14M0.00M3.60M
Debt Issuance and Repayment
Long-Term Debt Issuances
20.00M50.15M
Long-Term Debt Repayments
2.22M3.33M
Short-Term Debt issuances
Change in Capital Stock
Net Shares Issued and Repurchased
0.08M0.06M0.00M408.00568.000.00M
Net Equity Issued and Repurchased
0.03M0.35M0.03M7.79M6.42M3.54M5.51M6.80M10.50M
Misc.
Cash from Financing Activities
0.17M16.33M4.19M42.77M-0.00M6.62M22.98M7.47M25.44M73.68M-0.30M5.31M6.77M10.49M5.16M3.61M-2.22M-3.33M
Change in Cash
16.60M-5.93M-12.61M-14.19M-0.95M3.48M-9.54M1.54M-1.51M9.76M3.08M16.87M-18.70M7.63M-7.42M147.60M-80.65M-4.79M-17.06M-5.14M
Free Cash Flow
-10.74M-33.51M-13.54M-9.01M-6.79M-14.27M-11.96M-10.32M-5.79M-9.27M-15.26M-13.39M-12.64M-17.16M-19.80M-21.68M-23.71M-19.11M-20.74M-17.98M
Net Cash Flow
16.60M-5.93M-12.61M-10.41M-0.95M3.48M-9.54M1.54M-1.51M9.76M3.08M16.87M-18.70M7.63M-7.42M147.60M-80.65M-4.79M-17.06M-5.14M